Relay Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Relay Therapeutics

03/11/2022 21:03

* Relay Therapeutics Inc  RLAY.OQ  reported a quarterly
adjusted
loss of 76 cents​​ per share for the quarter ended in September.
The mean expectation of nine analysts for the quarter was for a
loss of 71 cents per share.
    * Revenue rose 51,551.7% to $344.00 million from a year ago;
analysts expected $1.66 million. 
    * Relay Therapeutics Inc's reported EPS for the quarter was
a loss
of 76 cents​.
    * The mean earnings estimate of analysts had fallen by
about 4.6%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Relay Therapeutics Inc shares had fallen by 4.2% this
quarter and lost 30.3% so far this year.
    * The company reported a quarterly loss of $84.17 million.
    * Wall Street's median 12-month price target for Relay
Therapeutics Inc is $44.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 09:03 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.71          -0.76          Missed
 Jun. 30 2022      -0.63          -0.71          Missed
 Mar. 31 2022      -0.62          -0.57          Beat
 Dec. 31 2021      -0.58          -0.62          Missed